Pages that link to "Q36328140"

The following pages link to The effect of genetic diversity on angiogenesis. (Q36328140):

Displaying 25 items.

• Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition (Q26822766) (← links)
• The classical pink-eyed dilution mutation affects angiogenic responsiveness (Q27304614) (← links)
• Gene expression microarray analysis of early oxygen-induced retinopathy in the rat (Q28577253) (← links)
• Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits (Q33335166) (← links)
• Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study (Q33849478) (← links)
• Genetic heterogeneity of lymphangiogenesis in different mouse strains (Q33947359) (← links)
• A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein (Q34328401) (← links)
• Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. (Q35043525) (← links)
• A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy (Q35088412) (← links)
• Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients (Q35638748) (← links)
• Differences in corneal phenotypes between destrin mutants are due to allelic difference and modified by genetic background (Q35818226) (← links)
• Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies (Q36172256) (← links)
• The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion (Q36378500) (← links)
• Common polymorphisms in angiogenesis. (Q36526587) (← links)
• Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy (Q36691776) (← links)
• Evaluating integrin function in models of angiogenesis and vascular permeability (Q36909861) (← links)
• The albino mutation of tyrosinase alters ocular angiogenic responsiveness (Q36931118) (← links)
• Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations (Q37344485) (← links)
• Brain Arteriovenous Malformation Pathogenesis: A Response-to-Injury Paradigm (Q37897171) (← links)
• Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors (Q38881898) (← links)
• Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development (Q41827770) (← links)
• Platelet activation: a link between psoriasis per se and subclinical atherosclerosis--a case-control study. (Q44199127) (← links)
• The mouse cornea micropocket angiogenesis assay (Q46941937) (← links)
• The -2549 insertion/deletion polymorphism in the promoter region of VEGF is associated with the risk of recurrent spontaneous abortion. (Q55260806) (← links)
• Retinopathy of prematurity: is genetic predisposition an important risk factor? (Q58191090) (← links)